American International Group, Inc. Bridge Bio Pharma, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $15,452 - $22,854	565 Added 0.99%	57,491 $1.78 Million
Q4 2023 Feb 13, 2024	SELL	$24.02 - $43.89 $5,524 - $10,094	-230 Reduced 0.4%	56,926 $2.3 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $15.5 Million - $32.2 Million	-920,656 Reduced 94.15%	57,156 $1.51 Million
Q2 2023 Aug 04, 2023	SELL	$13.29 - $18.01 $22.9 Million - $31.1 Million	-1,726,562 Reduced 63.84%	977,812 $16.8 Million
Q1 2023 May 12, 2023	SELL	$7.17 - $18.55 $7.28 Million - $18.8 Million	-1,015,711 Reduced 27.3%	2,704,374 $44.8 Million
Q4 2022 Feb 10, 2023	BUY	$6.74 - $11.52 $2,824 - $4,826	419 Added 0.01%	3,720,085 $28.3 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $5,573 - $8,676	702 Added 0.02%	3,719,666 $37 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $19,360 - $45,112	-3,716 Reduced 0.1%	3,718,964 $33.8 Million
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $27,216 - $63,629	-3,708 Reduced 0.1%	3,722,680 $37.8 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $28,632 - $134,379	-2,516 Reduced 0.07%	3,726,388 $62.2 Million
Q3 2021 Nov 19, 2021	BUY	$46.87 - $64.24 $172 Million - $236 Million	3,670,000 Added 6230.48%	3,728,904 $175 Million
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $172 Million - $236 Million	-3,671,398 Reduced 98.42%	58,904 $2.76 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $254,097 - $349,569	5,468 Added 0.15%	3,730,302 $227 Million
Q1 2021 May 07, 2021	BUY	$55.47 - $72.35 $21.2 Million - $27.7 Million	382,500 Added 11.44%	3,724,834 $229 Million
Q4 2020 Feb 12, 2021	SELL	$38.38 - $71.11 $87.4 Million - $162 Million	-2,277,594 Reduced 40.53%	3,342,334 $238 Million
Q3 2020 Nov 04, 2020	SELL	$27.2 - $42.19 $26,955 - $41,810	-991 Reduced 0.02%	5,619,928 $183 Million
Q2 2020 Aug 12, 2020	SELL	$22.22 - $35.69 $6.63 Million - $10.6 Million	-298,327 Reduced 5.04%	5,620,919 $183 Million
Q1 2020 May 04, 2020	SELL	$16.11 - $36.23 $13.3 Million - $29.9 Million	-825,146 Reduced 12.23%	5,919,246 $172 Million
Q4 2019 Feb 05, 2020	SELL	$17.96 - $46.63 $38,057 - $98,808	-2,119 Reduced 0.03%	6,744,392 $236 Million
Q3 2019 Nov 08, 2019	BUY	$20.13 - $32.38 $287,194 - $461,965	14,267 Added 0.21%	6,746,511 $145 Million
Q2 2019 Aug 13, 2019	BUY	$26.97 - $27.55 $182 Million - $185 Million	6,732,244 New	6,732,244 $182 Million

Others Institutions Holding BBIO

# of Institutions

292

Shares Held

175M

Call Options Held

8.66M

Put Options Held

2.76M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

31.1M
Shares

$775 Million
45.4% of portfolio
Viking Global Investors LP

25.1M
Shares

$627 Million
2.53% of portfolio
Vanguard Group Inc Valley Forge, PA

14.1M
Shares

$351 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$310 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$151 Million
67.33% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.7B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account